$39.72
0.56% today
NYSE, Apr 02, 09:19 pm CET
ISIN
NL0012169213
Symbol
QGEN

QIAGEN NV Stock price

$39.50
+1.28 3.35% 1M
-6.69 14.49% 6M
-6.30 13.76% YTD
-4.20 9.62% 1Y
-12.88 24.59% 3Y
-3.15 7.38% 5Y
+11.83 42.77% 10Y
NYSE, Closing price Tue, Apr 01 2025
-0.65 1.62%
ISIN
NL0012169213
Symbol
QGEN
Sector

Key metrics

Market capitalization $8.60b
Enterprise Value $8.96b
P/E (TTM) P/E ratio 106.33
EV/FCF (TTM) EV/FCF 17.69
EV/Sales (TTM) EV/Sales 4.53
P/S ratio (TTM) P/S ratio 4.35
P/B ratio (TTM) P/B ratio 2.39
Dividend yield 3.44%
Last dividend (FY24) $1.36
Revenue growth (TTM) Revenue growth 0.66%
Revenue (TTM) Revenue $1.98b
EBIT (operating result TTM) EBIT $494.96m
Free Cash Flow (TTM) Free Cash Flow $506.38m
Cash position $1.15b
EPS (TTM) EPS $0.37
P/E forward 19.84
P/S forward 4.24
EV/Sales forward 4.42
Short interest 2.25%
Show more

Is QIAGEN NV a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.

QIAGEN NV Stock Analysis

Unlock Scores for Free

Analyst Opinions

23 Analysts have issued a QIAGEN NV forecast:

13x Buy
57%
10x Hold
43%

Analyst Opinions

23 Analysts have issued a QIAGEN NV forecast:

Buy
57%
Hold
43%

Financial data from QIAGEN NV

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
1,978 1,978
1% 1%
100%
- Direct Costs 725 725
2% 2%
37%
1,253 1,253
2% 2%
63%
- Selling and Administrative Expenses 361 361
3% 3%
18%
- Research and Development Expense 193 193
3% 3%
10%
698 698
7% 7%
35%
- Depreciation and Amortization 203 203
1% 1%
10%
EBIT (Operating Income) EBIT 495 495
11% 11%
25%
Net Profit 84 84
76% 76%
4%

In millions USD.

Don't miss a Thing! We will send you all news about QIAGEN NV directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

QIAGEN NV Stock News

Neutral
Business Wire
one day ago
VENLO, Netherlands--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the QIAprep&amp Plasmodium Kit and two companion assays to support malaria research and surveillance efforts. This new solution combines sample preparation and quantitative PCR (qPCR) into a single workflow, providing a rapid and accessible tool for detecting malaria-causin...
Neutral
Business Wire
2 days ago
VENLO, Netherlands--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has filed its annual report, including its audited consolidated financial statements on Form 20-F, for the year ended December 31, 2024, with the U.S. Securities and Exchange Commission. The document can be accessed on QIAGEN's website here. QIAGEN will provide printed copies of ...
Neutral
Business Wire
28 days ago
GERMANTOWN, Md. & VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the U.S. Food and Drug Administration (FDA) has cleared the QIAstat-Dx Gastrointestinal Panel 2 Mini B for clinical use, further strengthening its syndromic testing portfolio in the United States. This marks QIAGEN's second FDA clearance of a QIAstat-D...
More QIAGEN NV News

Company Profile

QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.

Head office Netherlands
CEO Thierry Bernard
Employees 5,765
Founded 1996
Website www.qiagen.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today